limbrel and Mucositis
limbrel has been researched along with Mucositis* in 1 studies
Other Studies
1 other study(ies) available for limbrel and Mucositis
| Article | Year |
|---|---|
Reduction of oxidative stress blunts the NLRP3 inflammatory cascade in LPS stimulated human gingival fibroblasts and oral mucosal epithelial cells.
The therapeutic armamentarium for the treatment of oral mucositis is very poor. Catechin and baicalin are two natural flavonoids that have been individually reported to have a curative potential. Flavocoxid is a mixed extract containing baicalin and catechin showing antioxidant effects and anti-inflammatory activity mainly due to a dual inhibition of inducible cyclooxygenase (COX-2), 5-lipoxygenase (5-LOX) and NLRP3 pathway. The aim of this study was to evaluate the anti-inflammatory and anti-oxidant effects of flavocoxid in an "in vitro" model of oral mucositis induced by triggering an inflammatory phenotype in human gingival fibroblasts (GF) and human oral mucosal epithelial cells (EC). GF and EC were challenged with lipopolysaccharide (LPS 2 μg/ml) alone or in combination with flavocoxid (32 μg/ml). Flavocoxid increased Nrf2, prompted a marked reduction in malondialdehyde levels and reduced the expression of COX-2 and 5-LOX together with PGE Topics: Catechin; Drug Combinations; Epithelial Cells; Fibroblasts; Gingiva; Humans; Inflammasomes; Lipopolysaccharides; Mouth Mucosa; Mucositis; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress | 2022 |